Literature DB >> 7186051

Cell-mediated immunity in children with chronic cholestasis.

G Maggiore, C De Giacomo, M S Scotta, S Siena, R Maccario, A Vitiello.   

Abstract

Cell-mediated immune response was evaluated in 14 children with long-lasting intra- or extrahepatic cholestasis. Cell-mediated immunity was clearly depressed in children with intrahepatic cholestasis while children with extrahepatic biliary obstruction had a more modest and variable degree of impairment. This finding may be related to the longer duration of cholestasis and the higher total bile acid level in the intrahepatic compared to the extrahepatic group. In particular, in children with Byler disease, long-lasting, severe intrahepatic cholestasis was associated with depressed cell-mediated immunity and recurrent severe infections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7186051     DOI: 10.1097/00005176-198201030-00019

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  4 in total

1.  T-lymphocyte transformation in experimental obstructive jaundice: the role of serum-suppressive factors.

Authors:  R L Thompson; S Ranjbar; B J Rowlands
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

2.  Byler-like familial cholestasis in an extended kindred.

Authors:  B Bourke; N Goggin; D Walsh; S Kennedy; K D Setchell; B Drumm
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

3.  Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids.

Authors:  Marianne Wammers; Anna-Kathrin Schupp; Johannes G Bode; Christian Ehlting; Stephanie Wolf; René Deenen; Karl Köhrer; Dieter Häussinger; Dirk Graf
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.996

4.  Anti-inflammatory consequences of bile acid accumulation in virus-infected bile duct ligated mice.

Authors:  Stephanie Rattay; Dirk Graf; Andreas Kislat; Bernhard Homey; Diran Herebian; Dieter Häussinger; Hartmut Hengel; Albert Zimmermann; Anna-Kathrin Schupp
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.